Susan Drexler
Equibles does not estimate personal net worth.
Get an email with a short summary when Harmony Biosciences Holdings, Inc. publishes a filing, an earnings call transcript or a press release.
Get HRMY alertsAbout Susan Drexler
Susan Drexler is recorded as CFO at Harmony Biosciences Holdings, Inc. (HRMY). The proxy statement of Harmony Biosciences Holdings, Inc. reports total compensation of $368,549 for Susan Drexler in fiscal 2021, including a base salary of $83,103. Disclosed compensation is on record for 3 fiscal years. Harmony Biosciences Holdings, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Harmony Biosciences Holdings, Inc. includes Jeffrey Dayno (CEO), Jeffrey M. Dayno (CEO and Board Member), Peter Anastasiou (CEO, COO and Board Member) and 7 others.
Affiliation history
-
Current
Company network
Leadership on record at Harmony Biosciences Holdings, Inc.
- Jeffrey Dayno CEO
- Jeffrey M. Dayno CEO, Board Member
- Peter Anastasiou CEO, COO, Board Member
- Jeffrey S. Aronin Chairman
- Glenn Reicin CFO
- Sandip Kapadia CFO
- Eric Motley Board Member
- Linda Szyper Board Member
- Mark Graf Board Member
- Ron Philip Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Harmony Biosciences Holdings, Inc. (HRMY) | Former SVP and Chief Financial Officer | $83,103 | $368,549 |
| 2020 | Harmony Biosciences Holdings, Inc. (HRMY) | Former SVP and Chief Financial Officer | — | — |
| 2019 | Harmony Biosciences Holdings, Inc. (HRMY) | Former SVP and Chief Financial Officer | — | — |
Recent activity
No call appearances or filed executive changes recorded yet.